Partner With Us NRI

Alpa Laboratories Ltd

Company details

6M Return -0.61%
1Y Return -23.94%
Mkt Cap.(Cr) 137.71
Volume 23,693
Div Yield 0.00%
OI Chg %
Volume 23,693

Open Free Demat Account Online with ICICIDIRECT



Operating Profit

Profit after Tax


Reserves and Surplus



Operating Profit

Profit after Tax






Equity Capital: 121.73 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,728.09 -29,609.20
LAST 3M 42,048.80 -31,382.80
LAST 6M 65,127.04 16,114.05
LAST 12M 194,271.06 -118,498.61


Stock PE (TTM)


Promoter Holding


Book Value







  • Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of `Alpa Laboratories Limited`. In the year 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark `Alpa` which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals. The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company`s business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division.

Registered Address

33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446

Tel : 91-731-4294567
Email : is:alpalabs.com
Website : http://www.alpalabs.in


Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532878
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE385I01010

ICICIdirect Alpa Laboratories Ltd FAQ

You can buy Alpa Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Alpa Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Feb 08, 2023 04:01 PM the closing price of Alpa Laboratories Ltd was ₹ 65.45.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 08, 2023 04:01 PM, the market cap of Alpa Laboratories Ltd stood at ₹ 137.71.
The latest PE ratio of Alpa Laboratories Ltd as of Feb 08, 2023 04:01 PM is 28.58
The latest PB ratio of Alpa Laboratories Ltd as of Feb 08, 2023 04:01 PM is 0.83
The 52-week high of Alpa Laboratories Ltd is ₹ 89.55 while the 52-week low is ₹ 48.90

Download Our App

market app
market app